Quantbot Technologies LP Invests $432,000 in Exponent, Inc. $EXPO

Posted by Geri Gentry on Aug 29th, 2026

Quantbot Technologies LP bought a new stake in Exponent, Inc. (NASDAQ:EXPO – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 7,358 shares of the business services provider’s stock, valued at approximately $432,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. lifted its stake in Exponent by 87,479.8% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 230,335 shares of the business services provider’s stock worth $15,999,000 after purchasing an additional 230,072 shares in the last quarter. UBS Group AG grew its position in shares of Exponent by 29.7% during the 4th quarter. UBS Group AG now owns 176,404 shares of the business services provider’s stock valued at $12,253,000 after purchasing an additional 40,359 shares in the last quarter. Conestoga Capital Advisors LLC grew its position in shares of Exponent by 1.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 2,392,499 shares of the business services provider’s stock valued at $166,183,000 after purchasing an additional 31,303 shares in the last quarter. Quantinno Capital Management LP increased its holdings in shares of Exponent by 114.3% in the first quarter. Quantinno Capital Management LP now owns 36,614 shares of the business services provider’s stock worth $2,389,000 after purchasing an additional 19,528 shares during the period. Finally, New Age Alpha Advisors LLC raised its position in shares of Exponent by 785.8% in the fourth quarter. New Age Alpha Advisors LLC now owns 24,775 shares of the business services provider’s stock worth $1,721,000 after buying an additional 21,978 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on EXPO. JPMorgan Chase & Co. lifted their price objective on Exponent from $80.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. UBS Group set a $72.00 target price on Exponent and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a report on Friday, July 17th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $81.00.

Check Out Our Latest Research Report on Exponent

Exponent Price Performance

EXPO stock opened at $71.53 on Friday. The firm has a 50 day simple moving average of $64.33 and a two-hundred day simple moving average of $64.53. The stock has a market cap of $3.40 billion, a PE ratio of 32.08 and a beta of 0.68. Exponent, Inc. has a one year low of $51.91 and a one year high of $81.95.

Exponent (NASDAQ:EXPO – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The business services provider reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.05. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The firm had revenue of $171.61 million for the quarter, compared to analysts’ expectations of $144.99 million. During the same quarter last year, the company posted $0.52 EPS. The business’s quarterly revenue was up 12.0% on a year-over-year basis. On average, research analysts expect that Exponent, Inc. will post 2.31 EPS for the current fiscal year.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Friday, September 4th will be given a dividend of $0.31 per share. The ex-dividend date is Friday, September 4th. This represents a $1.24 dividend on an annualized basis and a yield of 1.7%. Exponent’s dividend payout ratio (DPR) is presently 55.61%.

Insiders Place Their Bets

In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of Exponent stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $66.28, for a total transaction of $113,139.96. Following the completion of the sale, the chief executive officer owned 129,108 shares of the company’s stock, valued at $8,557,278.24. The trade was a 1.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by insiders.

Exponent Profile

(Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.